Addressing Bias in Artificial Intelligence for Health Equity
/PRNewswire/ -- Dr. Michael Abramoff, Digital Diagnostics' founder and creator of the LumineticsCore™ AI system for diagnosing diabetic retinopathy, has...
Stay updated with breaking news from Michael Abramoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Dr. Michael Abramoff, Digital Diagnostics' founder and creator of the LumineticsCore™ AI system for diagnosing diabetic retinopathy, has...
/PRNewswire/ -- Digital Diagnostics, a leading artificial intelligence (AI) diagnostic healthcare company's flagship product, LumineticsCore™ (formerly...
Primary care might be the first setting where AI-driven tools allow for broader access to effective melanoma screening, amid continuing challenges in developing consumer apps for this purpose.
Nearly 10 million people with diabetes in the U.S. have diabetic retinopathy, or eye damage as a result from the disease, new research shows. Find out more about diabetic retinopathy and how it can be prevented.
/PRNewswire/ -- Digital Diagnostics – a leading AI diagnostics company on a mission to transform global healthcare – has rebranded its flagship product, the AI...